✦ LIBER ✦

Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate

✍ Scribed by Harald Dobnig; Jan J Stepan; David B Burr; Jiliang Li; Dana Michalská; Adrien Sipos; Helmut Petto; Astrid Fahrleitner-Pammer; Imre Pavo

Book ID: 111485777
Publisher: American Society for Bone and Mineral Research
Year: 2009
Tongue: English
Weight: 688 KB
Volume: 24
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.090527

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of teriparatide on serum calcium

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

✍ R. A. Wermers; C. P. Recknor; F. Cosman; L. Xie; E. V. Glass; J. H. Krege 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

Effects of one year daily teriparatide t

Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Sonja Gamsjaeger; Birgit Buchinger; Ruth Zoehrer; Roger Phipps; Klaus Klaushofer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Low bone mineral density is associated w

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis

✍ Jan J. Stepan; David B. Burr; Imre Pavo; Adrien Sipos; Dana Michalska; Jiliang L 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Effects of 1 year of daily teriparatide

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t

Intravenous zoledronic acid 5 mg in the

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate

✍ Michael McClung; Robert Recker; Paul Miller; Darrell Fiske; Jerome Minkoff; Audr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 189 KB

BONE MINERAL DENSITOMETRY AND QUANTITATI

BONE MINERAL DENSITOMETRY AND QUANTITATIVE BONE ULTRASOUND IN EVALUATING BONE CHANGES IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS TREATED WITH TERIPARATIDE

✍ V. Camozzi; G. Luisetto; M. Zangheri; F. Sanguin; F. Mantero; F. Lumachi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 83 KB